Stakeholder Engagement

Stakeholder Engagement

We recognize that we can’t address major health, environmental and economic challenges alone, so we collaborate with others who share our commitment and who bring their own unique expertise to the table.

We conduct stakeholder engagement at both the corporate and the local level, depending on the issue. We engage with industry, governments, policy makers, nongovernmental organizations (NGOs), opinion leaders, patient groups, academic organizations, our employees, and others to inform our policies, our practices, and the development of our products. Our intention is to build lasting relationships with our stakeholders; to understand their objectives, their expectations of our company, and the potential for collaboration; and to enhance mutual trust and understanding.

We strive to exchange information, views and recommendations; to share activities and progress toward key goals; and to work in partnership toward common objectives. Engagement may take the form of one-on-one meetings, expert-input forums, roundtable discussions, industry coalitions, or formal partnerships.

Stakeholder Groups

We engage with a diverse group of stakeholders to more fully understand their needs and expectations, and to gain insights that can inform our efforts to improve access to health care and foster progress toward solutions that benefit society and support our business.


We embrace the opportunity to engage with individual patients, patient advocacy organizations, and caregivers to better understand their health care journeys, expected outcomes and decision-making considerations. For more information on our work with patient groups, please click here.


We are committed to providing appropriate and balanced information to physicians and other health care providers about our medicines, vaccines and ongoing research. For more information on our interactions with health care professionals, please click here.


We work with payers worldwide to inform their understanding of the relationship between the prices of our products and the true value they deliver to patients and health care systems. Learn more about our access initiatives.


We work with policy makers, legislators, multilateral organizations, and governments worldwide to ensure that policy and regulatory environments globally, nationally, and locally foster patient access to medicines and vaccines, and that they are conducive to ethical business practices, science and innovation. Learn more about our public policy and advocacy positions.


We strive to create shareholder value by identifying opportunities to meet customer needs and by managing our business responsibly to achieve superior financial results over the long term. Learn more about how we engage with shareholders.


We work hard to identify the best organizations and individuals to collaborate with in order to address societal challenges and to inform debate on pressing issues. For more information about how we collaborate with others, please click here.


We work toward developing culturally appropriate mechanisms to engage and build relationships with our local community stakeholders. For more information on our contributions to communities, please click here.


We work to reduce the environmental effects of our operations and products and to promote sustainable environmental practices within the company, among our partners, and throughout our supply chain. For more information on our environmental performance, please click here.


We strive to foster a positive and inclusive working environment for our employees by providing resources to improve their health and that of their families, opportunities to further their professional development, and ways to get more involved in the communities where they live. For more information on our employee relations, please click here.


We strive to engage a diverse supplier base and to encourage responsible approaches on the part of suppliers regarding labor, employment, human rights, health and safety, ethics, diversity, and protection of the environment. For more information on our approach to procurement and supplier relations, please click here.


We engage with stakeholders through membership in numerous organizations. Within these groups, we aim to inform relevant debates in ways that are constructive and that ultimately foster improved patient access to medicines and vaccines globally. For more information, please click here.

We welcome your comments, questions and feedback to help guide the development of our programs, our reporting efforts and our corporate responsibility website. Contact us.

Patient Engagement

Our company’s mission is to continue to improve people’s health through the discovery, development and marketing of innovative products that contribute to the quality of life.

Our company’s mission is to continue to improve people’s health through the discovery, development and marketing of innovative products that contribute to the quality of life.

We embrace the opportunity to engage with individual patients, patient advocacy organizations, and caregivers to better understand their health care journeys, expected outcomes and decision-making—particularly as it relates to how they take medication—and the challenges they may encounter when taking several medications or treating multiple conditions. We feel that listening to patients is critical to inspiring effective and relevant medical and scientific innovation.

Julie Gerberding, M.D., M.P.H., was appointed chief patient officer in June 2016. In this role, Dr. Gerberding leads the company’s efforts to engage with patients and patient organizations to bring their perspectives into the company and help inform company decisions, and represents our company globally on patient-related matters.

We are committed to learning from the patient’s perspective and to empowering patients, caregivers and health care professionals by making public the results of clinical trials in a timely manner, whether the outcomes are positive or negative. Learn more.

We have a strong commitment to health literacy, and we believe that clear, simple information about clinical trials, diseases and medicine should be made easily available to people across a range of health-literacy levels. Learn more.

Because of the gaps in patient care and changes to health policy in such areas as vaccination, oncology, heart disease, HIV, hepatitis C infection, and other chronic conditions, there is a compelling need for the pharmaceutical industry to work more closely with patient organizations and other key stakeholders to better understand outcomes from the patient’s point of view, and to improve access to therapies, validate measurement tools, and increase awareness of diseases. We have a long history of collaboration with patient groups and health-related charities, including work aimed at improving knowledge and understanding of diseases and treatment options, resulting in informed decision-making among consumers in health care.